YU66799A - Itrakonazol koji pokazuje poboljšanu rastvorljivost, postupak za njegovo dobijanje i farmaceutska smesa za oralno davanje koja sadrži isti - Google Patents
Itrakonazol koji pokazuje poboljšanu rastvorljivost, postupak za njegovo dobijanje i farmaceutska smesa za oralno davanje koja sadrži istiInfo
- Publication number
- YU66799A YU66799A YU66799A YU66799A YU66799A YU 66799 A YU66799 A YU 66799A YU 66799 A YU66799 A YU 66799A YU 66799 A YU66799 A YU 66799A YU 66799 A YU66799 A YU 66799A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- same
- itraconazole
- exhibiting
- preparing
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Veličina čestica itrakonazola, kao nerastvorljivog leka, je smanjena i njegov kristalinitet je preveden iz kristalnog oblika u amorfni, čime je povećana njegova rastvorljivost u vodi i brzina rastvaranja. Poboljšan itrakonazol je primenjen u leku za oralno davanje.[The particle diameter of itraconazole, insoluble drug, is reduced and crystallinity thereof is changed from crystalline into amorphous, increasing water solubility and a dissolution rate thereof . The improved itraconazole is applied to an oral adminstration drug.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970024938A KR19990001564A (ko) | 1997-06-16 | 1997-06-16 | 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU66799A true YU66799A (sh) | 2002-06-19 |
Family
ID=19509733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU66799A YU66799A (sh) | 1997-06-16 | 1998-06-16 | Itrakonazol koji pokazuje poboljšanu rastvorljivost, postupak za njegovo dobijanje i farmaceutska smesa za oralno davanje koja sadrži isti |
Country Status (17)
Country | Link |
---|---|
US (1) | US6346533B1 (sh) |
EP (1) | EP0991646B1 (sh) |
JP (1) | JP2002504930A (sh) |
KR (1) | KR19990001564A (sh) |
CN (1) | CN1129598C (sh) |
AT (1) | ATE216699T1 (sh) |
AU (1) | AU7939298A (sh) |
BR (1) | BR9810124A (sh) |
CA (1) | CA2294398A1 (sh) |
DE (1) | DE69805070T2 (sh) |
DK (1) | DK0991646T3 (sh) |
ES (1) | ES2177022T3 (sh) |
HU (1) | HUP0004050A3 (sh) |
PL (1) | PL338631A1 (sh) |
PT (1) | PT991646E (sh) |
WO (1) | WO1998057967A1 (sh) |
YU (1) | YU66799A (sh) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0009176A (pt) | 1999-03-24 | 2001-12-18 | Fmc Corp | Partìcula granular, forma de dosagem, métodopara preparar uma partìcula granular, misturaseca, e, formulação granular |
IT1312115B1 (it) | 1999-06-24 | 2002-04-04 | Nicox Sa | Composti amorfi e relative composizioni farmaceutiche |
KR100694667B1 (ko) * | 1999-12-08 | 2007-03-14 | 동아제약주식회사 | 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제 |
KR20010097244A (ko) * | 2000-04-21 | 2001-11-08 | 유충식 | 위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법 |
KR100432949B1 (ko) * | 2000-06-13 | 2004-05-31 | 코오롱제약주식회사 | 생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법 |
US20030096013A1 (en) * | 2000-12-22 | 2003-05-22 | Jane Werling | Preparation of submicron sized particles with polymorph control |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US6951656B2 (en) | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US20040256749A1 (en) * | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US6884436B2 (en) * | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
US7193084B2 (en) * | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
ATE319432T1 (de) * | 2000-12-22 | 2006-03-15 | Baxter Int | Verfahren zur herstellung von submikropartikel- suspensionen pharmazeutischer substanzen |
US20040173146A1 (en) * | 2001-06-07 | 2004-09-09 | Figueroa Iddys D. | Application of a bioactive agent to a delivery substrate |
US20040173147A1 (en) * | 2001-06-07 | 2004-09-09 | Figueroa Iddys D. | Application of a bioactive agent to a delivery substrate |
US6962715B2 (en) * | 2001-10-24 | 2005-11-08 | Hewlett-Packard Development Company, L.P. | Method and dosage form for dispensing a bioactive substance |
WO2002100407A1 (en) * | 2001-06-12 | 2002-12-19 | Smartrix Technologies Inc. | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same |
WO2003011254A1 (en) * | 2001-07-31 | 2003-02-13 | Capricorn Pharma Inc. | Amorphous drug beads |
KR100438485B1 (ko) * | 2001-08-13 | 2004-07-09 | 한국디디에스제약 주식회사 | 아졸류 항진균제의 약제학적 조성물 |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
JP2005504090A (ja) * | 2001-09-26 | 2005-02-10 | バクスター・インターナショナル・インコーポレイテッド | 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製 |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
CA2363376A1 (en) * | 2001-11-16 | 2003-05-16 | Bernard Charles Sherman | Solid pharmaceutical compositions for oral administration comprising itraconazole |
US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
US7446107B2 (en) | 2002-02-15 | 2008-11-04 | Transform Pharmaceuticals, Inc. | Crystalline forms of conazoles and methods of making and using the same |
US7790905B2 (en) | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
WO2003101392A2 (en) | 2002-05-31 | 2003-12-11 | Transform Pharmaceuticals, Inc. | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
US20030224006A1 (en) | 2002-03-01 | 2003-12-04 | Zaworotko Michael J. | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
ES2334991T3 (es) * | 2002-03-26 | 2010-03-18 | Teva Pharmaceutical Industries Ltd. | Microparticulas de farmaco. |
JP2006500377A (ja) | 2002-06-21 | 2006-01-05 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 改善された溶解性を有する医薬組成物 |
KR100557680B1 (ko) * | 2002-11-23 | 2006-03-07 | 한국유나이티드제약 주식회사 | 이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법 |
US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
SI1438960T2 (sl) * | 2003-01-14 | 2013-04-30 | Cimex Pharma Ag | Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo |
GB0319797D0 (en) * | 2003-08-26 | 2003-09-24 | Leuven K U Res & Dev | Particle size reduction of poorly soluble drugs |
AU2004275764B2 (en) * | 2003-09-22 | 2010-01-14 | Baxter Healthcare S.A. | High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products |
US20050118265A1 (en) * | 2003-11-28 | 2005-06-02 | Anandi Krishnan | Antifungal oral dosage forms and the methods for preparation |
DE602005003557D1 (de) † | 2004-02-26 | 2008-01-10 | Zentiva As | Amorphe formen von of risedronat-mononatrium |
CN1294912C (zh) * | 2004-03-01 | 2007-01-17 | 上海医药工业研究院 | 伊曲康唑盐酸盐组合物及其冻干粉针 |
US20050203482A1 (en) * | 2004-03-15 | 2005-09-15 | Chinea Vanessa I. | Pharmaceutical dispensing apparatus and method |
US20050202051A1 (en) * | 2004-03-15 | 2005-09-15 | Chinea Vanessa I. | Pharmaceutical vehicle |
CA2598204C (en) | 2004-11-09 | 2015-01-13 | Board Of Regents, The University Of Texas System | Stabilized hme composition with small drug particles |
US20060182777A1 (en) * | 2005-02-15 | 2006-08-17 | Steve Kangas | Method of modulating drug release from a coated substrate |
AU2006259594A1 (en) * | 2005-06-14 | 2006-12-28 | Baxter Healthcare S.A. | Pharmaceutical formulations for minimizing drug-drug interactions |
US20070134341A1 (en) * | 2005-11-15 | 2007-06-14 | Kipp James E | Compositions of lipoxygenase inhibitors |
US20090152176A1 (en) * | 2006-12-23 | 2009-06-18 | Baxter International Inc. | Magnetic separation of fine particles from compositions |
US8426467B2 (en) * | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
US8722736B2 (en) * | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
GB0818403D0 (en) * | 2008-10-08 | 2008-11-12 | Univ Leuven Kath | Aqueous electrophoretic deposition |
EP2334845A2 (en) * | 2008-10-06 | 2011-06-22 | Katholieke Universiteit Leuven K.U. Leuven R&D | Functional layers of biomolecules and living cells, and a novel system to produce such |
CN104224687A (zh) * | 2014-09-28 | 2014-12-24 | 武汉药谷生物工程有限公司 | 硝酸异康唑阴道栓及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4368200A (en) | 1978-06-23 | 1983-01-11 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of (4-phenyl-piperazine-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)-methyl-1H-imidazoles and 1H-1,2,4-triazoles |
US4267179A (en) | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
US4490530A (en) | 1981-01-14 | 1984-12-25 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)-methyl-1H-imidazoles and 1H-1,2,4-triazoles |
JPS60139688A (ja) | 1983-12-28 | 1985-07-24 | Tokyo Tanabe Co Ltd | 無定形ジヒドロピリジン粉末製剤 |
GB8506792D0 (en) | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
US4870060A (en) | 1985-03-15 | 1989-09-26 | Janssen Pharmaceutica | Derivatives of γ-cylodextrin |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
EP0680324A4 (en) | 1993-01-27 | 1996-04-10 | Sepracor Inc | METHODS AND COMPOSITIONS USING (2R, 4S) ITRACONAZOLE. |
IT1263831B (it) | 1993-01-29 | 1996-09-04 | Paolo Chiesi | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
TW438601B (en) * | 1994-05-18 | 2001-06-07 | Janssen Pharmaceutica Nv | New mucoadhesive emulsion compositions and a process for the preparation thereof |
FR2722984B1 (fr) * | 1994-07-26 | 1996-10-18 | Effik Lab | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
US5750147A (en) * | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
NZ322907A (en) | 1995-11-23 | 1998-12-23 | Janssen Pharmaceutica Nv | Solid mixtures of cyclodextrins prepared via melt-extrusion |
US5686133A (en) * | 1996-01-31 | 1997-11-11 | Port Systems, L.L.C. | Water soluble pharmaceutical coating and method for producing coated pharmaceuticals |
DK0904060T3 (da) * | 1996-05-20 | 2004-04-13 | Janssen Pharmaceutica Nv | Antifungale præparater med forbedret biotilgængelighed |
-
1997
- 1997-06-16 KR KR1019970024938A patent/KR19990001564A/ko not_active Application Discontinuation
-
1998
- 1998-06-16 HU HU0004050A patent/HUP0004050A3/hu unknown
- 1998-06-16 DK DK98929878T patent/DK0991646T3/da active
- 1998-06-16 WO PCT/KR1998/000164 patent/WO1998057967A1/en not_active Application Discontinuation
- 1998-06-16 BR BR9810124-2A patent/BR9810124A/pt not_active IP Right Cessation
- 1998-06-16 DE DE69805070T patent/DE69805070T2/de not_active Expired - Fee Related
- 1998-06-16 AU AU79392/98A patent/AU7939298A/en not_active Abandoned
- 1998-06-16 PT PT98929878T patent/PT991646E/pt unknown
- 1998-06-16 JP JP50419399A patent/JP2002504930A/ja not_active Ceased
- 1998-06-16 AT AT98929878T patent/ATE216699T1/de not_active IP Right Cessation
- 1998-06-16 CN CN98806999A patent/CN1129598C/zh not_active Expired - Fee Related
- 1998-06-16 PL PL98338631A patent/PL338631A1/xx unknown
- 1998-06-16 ES ES98929878T patent/ES2177022T3/es not_active Expired - Lifetime
- 1998-06-16 YU YU66799A patent/YU66799A/sh unknown
- 1998-06-16 US US09/445,886 patent/US6346533B1/en not_active Expired - Fee Related
- 1998-06-16 EP EP98929878A patent/EP0991646B1/en not_active Expired - Lifetime
- 1998-06-16 CA CA002294398A patent/CA2294398A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK0991646T3 (da) | 2002-06-10 |
CN1129598C (zh) | 2003-12-03 |
CN1262682A (zh) | 2000-08-09 |
WO1998057967A1 (en) | 1998-12-23 |
KR19990001564A (ko) | 1999-01-15 |
AU7939298A (en) | 1999-01-04 |
DE69805070D1 (de) | 2002-05-29 |
HUP0004050A3 (en) | 2003-03-28 |
HUP0004050A2 (hu) | 2001-06-28 |
PT991646E (pt) | 2002-08-30 |
JP2002504930A (ja) | 2002-02-12 |
ES2177022T3 (es) | 2002-12-01 |
EP0991646A1 (en) | 2000-04-12 |
PL338631A1 (en) | 2000-11-06 |
CA2294398A1 (en) | 1998-12-23 |
EP0991646B1 (en) | 2002-04-24 |
BR9810124A (pt) | 2000-08-08 |
US6346533B1 (en) | 2002-02-12 |
DE69805070T2 (de) | 2002-11-07 |
ATE216699T1 (de) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU66799A (sh) | Itrakonazol koji pokazuje poboljšanu rastvorljivost, postupak za njegovo dobijanje i farmaceutska smesa za oralno davanje koja sadrži isti | |
IE894048L (en) | New therapeutically active compound and a process for its¹preparation | |
GEP20043315B (en) | Non-Peptide GnRH Agents, Methods For Their Preparation and Use Thereof | |
CA2092074A1 (en) | Rapidly disintegratable multiparticulate tablet | |
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
MD872G2 (ro) | Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului | |
DE69519685T2 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
AU2223095A (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
CA2093282A1 (en) | Intraoral medicament-releasing device | |
NZ514129A (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
IE64850B1 (en) | Therapeutically active substituted benzimidazole and process for its preparation | |
IL118162A0 (en) | Nanoparticles for oral administration of pharmaceutical agents of low solubility | |
CA2180178A1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
CA2216277A1 (en) | Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance | |
HUT50334A (en) | Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient | |
IL105276A (en) | (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
AU2420001A (en) | Methods and compositions for the treatment of pain | |
CA2210252A1 (en) | Crystalline trimetrexate salts and the process for making the same | |
HUT54166A (en) | Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
AU2907800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism | |
UA66925C2 (uk) | Поліморфні форми кристалічного цитрату азабіцикло[2.2.2]-октан-3-аміну, спосіб їх одержання, фармацевтична композиція та спосіб лікування блювання | |
GB9420748D0 (en) | 1,5 benzodiazepine derivatives | |
BG106236A (en) | Melt granulation | |
CA2187153A1 (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
HU9503696D0 (en) | New compounds, their pharmaceutically acceptable salts, process for producing them and pharmaceutical compositions containing them |